Save on Durysta with Coupons, Discounts & Savings Programs

Durysta is the brand name for bimatoprost and is available as an intracameral implant.

Durysta is available as an intracameral implant containing bimatoprost 10 mcg, in a drug delivery system.

Durysta is a prostaglandin and is used for the following:
Open-angle glaucoma High pressure in the eye (ocular hypertension)

Durysta is a prostaglandin. It helps fluid drain from inside the eye, which lowers eye pressure.

Durysta is a dissolvable implant that contains 10 mcg of medication. It’s placed in the affected eye(s) by a healthcare provider as a one-time procedure. The implant releases medication into your eye over time.

Durysta is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not use this medication in the following:

• Ocular or periocular infections
• Corneal endothelial cell dystrophy
• Prior corneal transplantation
• Absent or ruptured posterior lens capsule
• Hypersensitivity

Common side effects of Durysta:

• Eye redness
• Feeling like there’s something in your eye
• Eye pain
• Sensitivity to light
• Blood spot on the white of your eye
• Dry eye
• Eye irritation
• Higher eye pressure
• Blurry vision
• Iris inflammation
• Headache

Serious side effects are rare with Durysta. Contact your healthcare provider immediately if you experience any of the following.

• Eye infection (endophthalmitis): red eyes, sensitivity to light, eye pain, change in vision

There are no major drug interactions listed for Durysta. However, always let your physician and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking.

AbbVie Inc.

There are no adequate and well-controlled studies of Durysta
administration in pregnant women to inform a drug associated risk. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

• Bimatoprost